Effect of primary systemic carboplatin therapy in triple-negative breast cancer according to the Vanderbilt subtype. (March 2017) - Vetter, M.; Beck, H.; Schwarzer, F.; Stückrath, K.; Porsch, M.; Wickenhauser, C.; Strauß, H.-G.; Thomssen, C.